Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
33%(1 trials)

Phase Distribution

Ph phase_4
2
50%
Ph not_applicable
2
50%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution4 total trials
Phase 4Post-market surveillance
2(50.0%)
N/ANon-phased studies
2(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(3)
Other(1)

Detailed Status

Completed3
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 42 (50.0%)
N/A2 (50.0%)

Trials by Status

unknown125%
completed375%

Recent Activity

0 active trials
Showing 4 of 4
completedphase_4

A Comparison of Rocuronium 0.6 mg/kg and Remifentanil 2 µg/kg in Elderly Patients Over 80 Years

NCT04287426
unknownphase_4

Neuromuscular Blockade for Optimising Surgical Conditions During Spinal Surgery

NCT02778945
completednot_applicable

The Effect of Neuromuscular Blockade on the Composite Variability Index (CVI) During Laryngoscopy

NCT01450813
completednot_applicable

Influence of the Neuromuscular Blockade on Mask Ventilation

NCT02318810

Clinical Trials (4)

Showing 4 of 4 trials
NCT04287426Phase 4

A Comparison of Rocuronium 0.6 mg/kg and Remifentanil 2 µg/kg in Elderly Patients Over 80 Years

Completed
NCT02778945Phase 4

Neuromuscular Blockade for Optimising Surgical Conditions During Spinal Surgery

Unknown
NCT01450813Not Applicable

The Effect of Neuromuscular Blockade on the Composite Variability Index (CVI) During Laryngoscopy

Completed
NCT02318810Not Applicable

Influence of the Neuromuscular Blockade on Mask Ventilation

Completed

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4